Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Monitor the Fruzaqla Treatment of Adults With Metastatic Colorectal Cancer (mCRC) in South Korea
Sponsor: Takeda
Summary
The purpose of this study is to estimate the proportion of all adverse events (AEs) including serious adverse events (SAEs) occurring with the use of fruquintinib among adult participants who have been administered fruquintinib as per the approved indications.
Official title: Post-Marketing Surveillance (Usage Results Study) of Fruzaqla Capsule (Fruquintinib) for the Approved Indications in South Korea
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
600
Start Date
2025-09-29
Completion Date
2031-03-01
Last Updated
2026-02-27
Healthy Volunteers
No
Conditions
Interventions
No intervention
As this is an observational study, no intervention will be administered.
Locations (1)
Yonsei University Hospital
Seoul, South Korea